Mycotoxins: A Broader Perspective and Custom Formulations for Ultimate Personalized CareHeld...September 18-20, 2020
Online Live-Streamed Conference Supported by SPOTME
Watch this 7-minute video
2020 Annual Conference on Environmental Toxins and Genomics —Mycotoxins: A Broader Perspective, and Custom Formulations for Ultimate Personalized Careexplores the latest research across multiple fields on how the onslaught of mycotoxins affects us all, with the greatest impact on those with genetic vulnerabilities.
The functional medicine community now recognizes that mycotoxins are a more serious problem than previously understood, requiring better approaches to tackle this severe issue. Adsorbents and your usual practices may not be enough.
One highlight of this conference is the research by Emily Givler (DSC), Beth O'Hara (FND), and Neil Nathan (MD) on the specific Phase II pathways most in need of support for each particular mycotoxin.
In this conference, you will learn(Click the highlighted speaker names to watch our interviews of the speakers with Bob Miller):
• Mycotoxins 101 (Dr. William Shaw)
• Conditions Associated with Mycotoxins (Dr. Andrew Campbell, MD)
• Mycotoxin Detox Strategies from Neil Nathan (MD) and Jill Carnahan (MD)
• Overview of Mycotoxin Testing (Sandeep Gupta, MD
• Home Remediation Strategies (Dr. Sandeep Gupta, MD)
• Oxalates and Mycotoxins (Emily Givler, DSc
• Mycotoxins and MCAS (Beth O'Hara,FND
• Mycotoxins and Cytokine Storm (Bob Miller, CTN)
• Mycotoxins and Nitric Oxide (Mackay Rippey, LAc)
• Deuterium and Detoxification Weaknesses (Stephanie Seneff, , PhD)
• Increased Inflammation from IL-13/IL-4 Mutations and MCAS (Mast Cell Activation Syndrome)Mackay Rippey,LAc)
• Mycotoxins and Glucuronidation (Beth O'Hara, FND)
• Mycotoxins and Glutathione Conjugation (Emily Givler, DSC)
• Mycotoxins and Adrenal Fatigue (Joel Rosen, DC)
• Essential Oils and Mycotoxins (Carley Sink and Lari Young, MD)
This conference demonstrates how to use Your Genomic Resource genetic testing and Functional Genomic Analysis software to identify weaknesses in detoxification pathways and how to provide support for each patient. There is no one-size-fits-all solution.
Finally, we teach you how to customize proprietary compound supplements for your patients.
Bob Miller, CTN
NutriGenetic Research Institute
